![]() |
Name |
muyocopronol A
|
Molecular Formula | C32H58O11 | |
IUPAC Name* |
2,3,4,5,6-pentahydroxyhexyl3,7,11-trihydroxy-14-(hydroxymethyl)-2,4,6,8,10,12,16-heptamethyloctadeca-4,8,12-trienoate
|
|
SMILES |
CCC(C)CC(C=C(C)C(O)C(C)C=C(C)C(O)C(C)C=C(C)C(O)C(C)C(=O)OCC(O)C(O)C(O)C(O)CO)CO
|
|
InChI |
InChI=1S/C32H58O11/c1-9-17(2)10-24(14-33)13-22(7)28(38)19(4)11-18(3)27(37)20(5)12-21(6)29(39)23(8)32(42)43-16-26(36)31(41)30(40)25(35)15-34/h11-13,17,19-20,23-31,33-41H,9-10,14-16H2,1-8H3/b18-11+,21-12+,22-13+/t17?,19-,20-,23+,24?,25+,26+,27+,28-,29+,30+,31+/m0/s1
|
|
InChIKey |
XMRISQGLAMSUQI-PEZHCRFFSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 618.81 | ALogp: | 0.8 |
HBD: | 9 | HBA: | 11 |
Rotatable Bonds: | 20 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 208.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 43 | QED Weighted: | 0.07 |
Caco-2 Permeability: | -5.054 | MDCK Permeability: | 0.00012370 |
Pgp-inhibitor: | 0.817 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.977 | 20% Bioavailability (F20%): | 0.032 |
30% Bioavailability (F30%): | 0.87 |
Blood-Brain-Barrier Penetration (BBB): | 0.25 | Plasma Protein Binding (PPB): | 64.69% |
Volume Distribution (VD): | 0.588 | Fu: | 6.87% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.045 |
CYP2C19-inhibitor: | 0.001 | CYP2C19-substrate: | 0.155 |
CYP2C9-inhibitor: | 0 | CYP2C9-substrate: | 0.126 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.061 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.131 |
Clearance (CL): | 2.856 | Half-life (T1/2): | 0.227 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.83 |
Drug-inuced Liver Injury (DILI): | 0.92 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.002 |
Skin Sensitization: | 0.004 | Carcinogencity: | 0.007 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.004 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005724 | ![]() |
0.700 | D0B8SY | ![]() |
0.329 | ||
ENC005725 | ![]() |
0.571 | D02KFP | ![]() |
0.326 | ||
ENC005021 | ![]() |
0.328 | D0P7EK | ![]() |
0.248 | ||
ENC005666 | ![]() |
0.273 | D09MXS | ![]() |
0.248 | ||
ENC004454 | ![]() |
0.273 | D0RQ2W | ![]() |
0.245 | ||
ENC005901 | ![]() |
0.267 | D01OIL | ![]() |
0.232 | ||
ENC005665 | ![]() |
0.262 | D0T6VD | ![]() |
0.226 | ||
ENC005126 | ![]() |
0.262 | D0VM8K | ![]() |
0.218 | ||
ENC003294 | ![]() |
0.259 | D06HZY | ![]() |
0.205 | ||
ENC003293 | ![]() |
0.248 | D02DJS | ![]() |
0.202 |